N-methyl-N-[2-[1-(4-methylphenyl)cyclopropyl]ethyl]acetamide;2-[methyl-[2-[1-(4-methylphenyl)cyclopropyl]ethyl]amino]acetamide;2-[methyl-[2-[1-(4-methylphenyl)cyclopropyl]ethyl]amino]ethanol;2-methyl-N-[2-[1-(4-methylphenyl)cyclopropyl]ethyl]propanamide;N-[2-[1-(4-methylphenyl)cyclopropyl]ethyl]acetamide;4-[2-[1-(4-methylphenyl)cyclopropyl]ethyl]morpholine;4-[2-[1-(4-methylphenyl)cyclopropyl]ethyl]piperazin-2-one;1-[2-[1-(4-methylphenyl)cyclopropyl]ethyl]piperidin-4-ol;(3S)-1-[2-[1-(4-methylphenyl)cyclopropyl]ethyl]pyrrolidin-3-ol;4-[2-[1-(4-methylphenyl)cyclopropyl]ethyl]-1,4-thiazinane 1,1-dioxide

C156H224N12O11S — CID 160771056

IUPACN-methyl-N-[2-[1-(4-methylphenyl)cyclopropyl]ethyl]acetamide;2-[methyl-[2-[1-(4-methylphenyl)cyclopropyl]ethyl]amino]acetamide;2-[methyl-[2-[1-(4-methylphenyl)cyclopropyl]ethyl]amino]ethanol;2-methyl-N-[2-[1-(4-methylphenyl)cyclopropyl]ethyl]propanamide;N-[2-[1-(4-methylphenyl)cyclopropyl]ethyl]acetamide;4-[2-[1-(4-methylphenyl)cyclopropyl]ethyl]morpholine;4-[2-[1-(4-methylphenyl)cyclopropyl]ethyl]piperazin-2-one;1-[2-[1-(4-methylphenyl)cyclopropyl]ethyl]piperidin-4-ol;(3S)-1-[2-[1-(4-methylphenyl)cyclopropyl]ethyl]pyrrolidin-3-ol;4-[2-[1-(4-methylphenyl)cyclopropyl]ethyl]-1,4-thiazinane 1,1-dioxide
SMILESCC(=O)N(C)CCC1(c2ccc(C)cc2)CC1.CC(=O)NCCC1(c2ccc(C)cc2)CC1.Cc1ccc(C2(CCN(C)CC(N)=O)CC2)cc1.Cc1ccc(C2(CCN(C)CCO)CC2)cc1.Cc1ccc(C2(CCN3CCC(O)CC3)CC2)cc1.Cc1ccc(C2(CCN3CCNC(=O)C3)CC2)cc1.Cc1ccc(C2(CCN3CCOCC3)CC2)cc1.Cc1ccc(C2(CCN3CCS(=O)(=O)CC3)CC2)cc1.Cc1ccc(C2(CCN3CC[C@H](O)C3)CC2)cc1.Cc1ccc(C2(CCNC(=O)C(C)C)CC2)cc1
InChIInChI=1S/C17H25NO.C16H22N2O.C16H23NO2S.3C16H23NO.C15H22N2O.C15H21NO.C15H23NO.C14H19NO/c1-14-2-4-15(5-3-14)17(8-9-17)10-13-18-11-6-16(19)7-12-18;1-13-2-4-14(5-3-13)16(6-7-16)8-10-18-11-9-17-15(19)12-18;1-14-2-4-15(5-3-14)16(6-7-16)8-9-17-10-12-20(18,19)13-11-17;1-13-2-4-14(5-3-13)16(7-8-16)9-11-17-10-6-15(18)12-17;1-14-2-4-15(5-3-14)16(6-7-16)8-9-17-10-12-18-13-11-17;1-12(2)15(18)17-11-10-16(8-9-16)14-6-4-13(3)5-7-14;1-12-3-5-13(6-4-12)15(7-8-15)9-10-17(2)11-14(16)18;1-12-4-6-14(7-5-12)15(8-9-15)10-11-16(3)13(2)17;1-13-3-5-14(6-4-13)15(7-8-15)9-10-16(2)11-12-17;1-11-3-5-13(6-4-11)14(7-8-14)9-10-15-12(2)16/h2-5,16,19H,6-13H2,1H3;2-5H,6-12H2,1H3,(H,17,19);2-5H,6-13H2,1H3;2-5,15,18H,6-12H2,1H3;2-5H,6-13H2,1H3;4-7,12H,8-11H2,1-3H3,(H,17,18);3-6H,7-11H2,1-2H3,(H2,16,18);4-7H,8-11H2,1-3H3;3-6,17H,7-12H2,1-2H3;3-6H,7-10H2,1-2H3,(H,15,16)/t;;;15-;;;;;;/m...0....../s1
InChIKeyRZIABDXPPAHBGL-ARJOZUONSA-N
MW2475.65 g/mol
LogP24.91
Rot. Bonds45

About N-methyl-N-[2-[1-(4-methylphenyl)cyclopropyl]ethyl]acetamide;2-[methyl-[2-[1-(4-methylphenyl)cyclopropyl]ethyl]amino]acetamide;2-[methyl-[2-[1-(4-methylphenyl)cyclopropyl]ethyl]amino]ethanol;2-methyl-N-[2-[1-(4-methylphenyl)cyclopropyl]ethyl]propanamide;N-[2-[1-(4-methylphenyl)cyclopropyl]ethyl]acetamide;4-[2-[1-(4-methylphenyl)cyclopropyl]ethyl]morpholine;4-[2-[1-(4-methylphenyl)cyclopropyl]ethyl]piperazin-2-one;1-[2-[1-(4-methylphenyl)cyclopropyl]ethyl]piperidin-4-ol;(3S)-1-[2-[1-(4-methylphenyl)cyclopropyl]ethyl]pyrrolidin-3-ol;4-[2-[1-(4-methylphenyl)cyclopropyl]ethyl]-1,4-thiazinane 1,1-dioxide

N-methyl-N-[2-[1-(4-methylphenyl)cyclopropyl]ethyl]acetamide;2-[methyl-[2-[1-(4-methylphenyl)cyclopropyl]ethyl]amino]acetamide;2-[methyl-[2-[1-(4-methylphenyl)cyclopropyl]ethyl]amino]ethanol;2-methyl-N-[2-[1-(4-methylphenyl)cyclopropyl]ethyl]propanamide;N-[2-[1-(4-methylphenyl)cyclopropyl]ethyl]acetamide;4-[2-[1-(4-methylphenyl)cyclopropyl]ethyl]morpholine;4-[2-[1-(4-methylphenyl)cyclopropyl]ethyl]piperazin-2-one;1-[2-[1-(4-methylphenyl)cyclopropyl]ethyl]piperidin-4-ol;(3S)-1-[2-[1-(4-methylphenyl)cyclopropyl]ethyl]pyrrolidin-3-ol;4-[2-[1-(4-methylphenyl)cyclopropyl]ethyl]-1,4-thiazinane 1,1-dioxide (PubChem CID 160771056) has the molecular formula C156H224N12O11S and a molecular weight of 2475.65 g/mol. Its IUPAC name is N-methyl-N-[2-[1-(4-methylphenyl)cyclopropyl]ethyl]acetamide;2-[methyl-[2-[1-(4-methylphenyl)cyclopropyl]ethyl]amino]acetamide;2-[methyl-[2-[1-(4-methylphenyl)cyclopropyl]ethyl]amino]ethanol;2-methyl-N-[2-[1-(4-methylphenyl)cyclopropyl]ethyl]propanamide;N-[2-[1-(4-methylphenyl)cyclopropyl]ethyl]acetamide;4-[2-[1-(4-methylphenyl)cyclopropyl]ethyl]morpholine;4-[2-[1-(4-methylphenyl)cyclopropyl]ethyl]piperazin-2-one;1-[2-[1-(4-methylphenyl)cyclopropyl]ethyl]piperidin-4-ol;(3S)-1-[2-[1-(4-methylphenyl)cyclopropyl]ethyl]pyrrolidin-3-ol;4-[2-[1-(4-methylphenyl)cyclopropyl]ethyl]-1,4-thiazinane 1,1-dioxide.

Molecular Properties

Compound NameN-methyl-N-[2-[1-(4-methylphenyl)cyclopropyl]ethyl]acetamide;2-[methyl-[2-[1-(4-methylphenyl)cyclopropyl]ethyl]amino]acetamide;2-[methyl-[2-[1-(4-methylphenyl)cyclopropyl]ethyl]amino]ethanol;2-methyl-N-[2-[1-(4-methylphenyl)cyclopropyl]ethyl]propanamide;N-[2-[1-(4-methylphenyl)cyclopropyl]ethyl]acetamide;4-[2-[1-(4-methylphenyl)cyclopropyl]ethyl]morpholine;4-[2-[1-(4-methylphenyl)cyclopropyl]ethyl]piperazin-2-one;1-[2-[1-(4-methylphenyl)cyclopropyl]ethyl]piperidin-4-ol;(3S)-1-[2-[1-(4-methylphenyl)cyclopropyl]ethyl]pyrrolidin-3-ol;4-[2-[1-(4-methylphenyl)cyclopropyl]ethyl]-1,4-thiazinane 1,1-dioxide
PubChem CID160771056
Molecular FormulaC156H224N12O11S
Molecular Weight2475.65 g/mol
Exact Mass2473.71
IUPAC NameN-methyl-N-[2-[1-(4-methylphenyl)cyclopropyl]ethyl]acetamide;2-[methyl-[2-[1-(4-methylphenyl)cyclopropyl]ethyl]amino]acetamide;2-[methyl-[2-[1-(4-methylphenyl)cyclopropyl]ethyl]amino]ethanol;2-methyl-N-[2-[1-(4-methylphenyl)cyclopropyl]ethyl]propanamide;N-[2-[1-(4-methylphenyl)cyclopropyl]ethyl]acetamide;4-[2-[1-(4-methylphenyl)cyclopropyl]ethyl]morpholine;4-[2-[1-(4-methylphenyl)cyclopropyl]ethyl]piperazin-2-one;1-[2-[1-(4-methylphenyl)cyclopropyl]ethyl]piperidin-4-ol;(3S)-1-[2-[1-(4-methylphenyl)cyclopropyl]ethyl]pyrrolidin-3-ol;4-[2-[1-(4-methylphenyl)cyclopropyl]ethyl]-1,4-thiazinane 1,1-dioxide
SMILESCC(=O)N(C)CCC1(c2ccc(C)cc2)CC1.CC(=O)NCCC1(c2ccc(C)cc2)CC1.Cc1ccc(C2(CCN(C)CC(N)=O)CC2)cc1.Cc1ccc(C2(CCN(C)CCO)CC2)cc1.Cc1ccc(C2(CCN3CCC(O)CC3)CC2)cc1.Cc1ccc(C2(CCN3CCNC(=O)C3)CC2)cc1.Cc1ccc(C2(CCN3CCOCC3)CC2)cc1.Cc1ccc(C2(CCN3CCS(=O)(=O)CC3)CC2)cc1.Cc1ccc(C2(CCN3CC[C@H](O)C3)CC2)cc1.Cc1ccc(C2(CCNC(=O)C(C)C)CC2)cc1
InChIInChI=1S/C17H25NO.C16H22N2O.C16H23NO2S.3C16H23NO.C15H22N2O.C15H21NO.C15H23NO.C14H19NO/c1-14-2-4-15(5-3-14)17(8-9-17)10-13-18-11-6-16(19)7-12-18;1-13-2-4-14(5-3-13)16(6-7-16)8-10-18-11-9-17-15(19)12-18;1-14-2-4-15(5-3-14)16(6-7-16)8-9-17-10-12-20(18,19)13-11-17;1-13-2-4-14(5-3-13)16(7-8-16)9-11-17-10-6-15(18)12-17;1-14-2-4-15(5-3-14)16(6-7-16)8-9-17-10-12-18-13-11-17;1-12(2)15(18)17-11-10-16(8-9-16)14-6-4-13(3)5-7-14;1-12-3-5-13(6-4-12)15(7-8-15)9-10-17(2)11-14(16)18;1-12-4-6-14(7-5-12)15(8-9-15)10-11-16(3)13(2)17;1-13-3-5-14(6-4-13)15(7-8-15)9-10-16(2)11-12-17;1-11-3-5-13(6-4-11)14(7-8-14)9-10-15-12(2)16/h2-5,16,19H,6-13H2,1H3;2-5H,6-12H2,1H3,(H,17,19);2-5H,6-13H2,1H3;2-5,15,18H,6-12H2,1H3;2-5H,6-13H2,1H3;4-7,12H,8-11H2,1-3H3,(H,17,18);3-6H,7-11H2,1-2H3,(H2,16,18);4-7H,8-11H2,1-3H3;3-6,17H,7-12H2,1-2H3;3-6H,7-10H2,1-2H3,(H,15,16)/t;;;15-;;;;;;/m...0....../s1
InChIKeyRZIABDXPPAHBGL-ARJOZUONSA-N
XLogP24.91
TPSA277.44 Ų
H-Bond Donors7
H-Bond Acceptors18
Rotatable Bonds45
Heavy Atoms180
Complexity—

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002475.65
LogP ≤ 524.91
H-Bond Donors ≤ 57
H-Bond Acceptors ≤ 1018

Analyze N-methyl-N-[2-[1-(4-methylphenyl)cyclopropyl]ethyl]acetamide;2-[methyl-[2-[1-(4-methylphenyl)cyclopropyl]ethyl]amino]acetamide;2-[methyl-[2-[1-(4-methylphenyl)cyclopropyl]ethyl]amino]ethanol;2-methyl-N-[2-[1-(4-methylphenyl)cyclopropyl]ethyl]propanamide;N-[2-[1-(4-methylphenyl)cyclopropyl]ethyl]acetamide;4-[2-[1-(4-methylphenyl)cyclopropyl]ethyl]morpholine;4-[2-[1-(4-methylphenyl)cyclopropyl]ethyl]piperazin-2-one;1-[2-[1-(4-methylphenyl)cyclopropyl]ethyl]piperidin-4-ol;(3S)-1-[2-[1-(4-methylphenyl)cyclopropyl]ethyl]pyrrolidin-3-ol;4-[2-[1-(4-methylphenyl)cyclopropyl]ethyl]-1,4-thiazinane 1,1-dioxide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of N-methyl-N-[2-[1-(4-methylphenyl)cyclopropyl]ethyl]acetamide;2-[methyl-[2-[1-(4-methylphenyl)cyclopropyl]ethyl]amino]acetamide;2-[methyl-[2-[1-(4-methylphenyl)cyclopropyl]ethyl]amino]ethanol;2-methyl-N-[2-[1-(4-methylphenyl)cyclopropyl]ethyl]propanamide;N-[2-[1-(4-methylphenyl)cyclopropyl]ethyl]acetamide;4-[2-[1-(4-methylphenyl)cyclopropyl]ethyl]morpholine;4-[2-[1-(4-methylphenyl)cyclopropyl]ethyl]piperazin-2-one;1-[2-[1-(4-methylphenyl)cyclopropyl]ethyl]piperidin-4-ol;(3S)-1-[2-[1-(4-methylphenyl)cyclopropyl]ethyl]pyrrolidin-3-ol;4-[2-[1-(4-methylphenyl)cyclopropyl]ethyl]-1,4-thiazinane 1,1-dioxide?
The IUPAC name of N-methyl-N-[2-[1-(4-methylphenyl)cyclopropyl]ethyl]acetamide;2-[methyl-[2-[1-(4-methylphenyl)cyclopropyl]ethyl]amino]acetamide;2-[methyl-[2-[1-(4-methylphenyl)cyclopropyl]ethyl]amino]ethanol;2-methyl-N-[2-[1-(4-methylphenyl)cyclopropyl]ethyl]propanamide;N-[2-[1-(4-methylphenyl)cyclopropyl]ethyl]acetamide;4-[2-[1-(4-methylphenyl)cyclopropyl]ethyl]morpholine;4-[2-[1-(4-methylphenyl)cyclopropyl]ethyl]piperazin-2-one;1-[2-[1-(4-methylphenyl)cyclopropyl]ethyl]piperidin-4-ol;(3S)-1-[2-[1-(4-methylphenyl)cyclopropyl]ethyl]pyrrolidin-3-ol;4-[2-[1-(4-methylphenyl)cyclopropyl]ethyl]-1,4-thiazinane 1,1-dioxide (CID 160771056) is N-methyl-N-[2-[1-(4-methylphenyl)cyclopropyl]ethyl]acetamide;2-[methyl-[2-[1-(4-methylphenyl)cyclopropyl]ethyl]amino]acetamide;2-[methyl-[2-[1-(4-methylphenyl)cyclopropyl]ethyl]amino]ethanol;2-methyl-N-[2-[1-(4-methylphenyl)cyclopropyl]ethyl]propanamide;N-[2-[1-(4-methylphenyl)cyclopropyl]ethyl]acetamide;4-[2-[1-(4-methylphenyl)cyclopropyl]ethyl]morpholine;4-[2-[1-(4-methylphenyl)cyclopropyl]ethyl]piperazin-2-one;1-[2-[1-(4-methylphenyl)cyclopropyl]ethyl]piperidin-4-ol;(3S)-1-[2-[1-(4-methylphenyl)cyclopropyl]ethyl]pyrrolidin-3-ol;4-[2-[1-(4-methylphenyl)cyclopropyl]ethyl]-1,4-thiazinane 1,1-dioxide.
What is the SMILES notation for N-methyl-N-[2-[1-(4-methylphenyl)cyclopropyl]ethyl]acetamide;2-[methyl-[2-[1-(4-methylphenyl)cyclopropyl]ethyl]amino]acetamide;2-[methyl-[2-[1-(4-methylphenyl)cyclopropyl]ethyl]amino]ethanol;2-methyl-N-[2-[1-(4-methylphenyl)cyclopropyl]ethyl]propanamide;N-[2-[1-(4-methylphenyl)cyclopropyl]ethyl]acetamide;4-[2-[1-(4-methylphenyl)cyclopropyl]ethyl]morpholine;4-[2-[1-(4-methylphenyl)cyclopropyl]ethyl]piperazin-2-one;1-[2-[1-(4-methylphenyl)cyclopropyl]ethyl]piperidin-4-ol;(3S)-1-[2-[1-(4-methylphenyl)cyclopropyl]ethyl]pyrrolidin-3-ol;4-[2-[1-(4-methylphenyl)cyclopropyl]ethyl]-1,4-thiazinane 1,1-dioxide?
The canonical SMILES for N-methyl-N-[2-[1-(4-methylphenyl)cyclopropyl]ethyl]acetamide;2-[methyl-[2-[1-(4-methylphenyl)cyclopropyl]ethyl]amino]acetamide;2-[methyl-[2-[1-(4-methylphenyl)cyclopropyl]ethyl]amino]ethanol;2-methyl-N-[2-[1-(4-methylphenyl)cyclopropyl]ethyl]propanamide;N-[2-[1-(4-methylphenyl)cyclopropyl]ethyl]acetamide;4-[2-[1-(4-methylphenyl)cyclopropyl]ethyl]morpholine;4-[2-[1-(4-methylphenyl)cyclopropyl]ethyl]piperazin-2-one;1-[2-[1-(4-methylphenyl)cyclopropyl]ethyl]piperidin-4-ol;(3S)-1-[2-[1-(4-methylphenyl)cyclopropyl]ethyl]pyrrolidin-3-ol;4-[2-[1-(4-methylphenyl)cyclopropyl]ethyl]-1,4-thiazinane 1,1-dioxide is CC(=O)N(C)CCC1(c2ccc(C)cc2)CC1.CC(=O)NCCC1(c2ccc(C)cc2)CC1.Cc1ccc(C2(CCN(C)CC(N)=O)CC2)cc1.Cc1ccc(C2(CCN(C)CCO)CC2)cc1.Cc1ccc(C2(CCN3CCC(O)CC3)CC2)cc1.Cc1ccc(C2(CCN3CCNC(=O)C3)CC2)cc1.Cc1ccc(C2(CCN3CCOCC3)CC2)cc1.Cc1ccc(C2(CCN3CCS(=O)(=O)CC3)CC2)cc1.Cc1ccc(C2(CCN3CC[C@H](O)C3)CC2)cc1.Cc1ccc(C2(CCNC(=O)C(C)C)CC2)cc1.
What is the InChIKey of N-methyl-N-[2-[1-(4-methylphenyl)cyclopropyl]ethyl]acetamide;2-[methyl-[2-[1-(4-methylphenyl)cyclopropyl]ethyl]amino]acetamide;2-[methyl-[2-[1-(4-methylphenyl)cyclopropyl]ethyl]amino]ethanol;2-methyl-N-[2-[1-(4-methylphenyl)cyclopropyl]ethyl]propanamide;N-[2-[1-(4-methylphenyl)cyclopropyl]ethyl]acetamide;4-[2-[1-(4-methylphenyl)cyclopropyl]ethyl]morpholine;4-[2-[1-(4-methylphenyl)cyclopropyl]ethyl]piperazin-2-one;1-[2-[1-(4-methylphenyl)cyclopropyl]ethyl]piperidin-4-ol;(3S)-1-[2-[1-(4-methylphenyl)cyclopropyl]ethyl]pyrrolidin-3-ol;4-[2-[1-(4-methylphenyl)cyclopropyl]ethyl]-1,4-thiazinane 1,1-dioxide?
The InChIKey is RZIABDXPPAHBGL-ARJOZUONSA-N. The full InChI is InChI=1S/C17H25NO.C16H22N2O.C16H23NO2S.3C16H23NO.C15H22N2O.C15H21NO.C15H23NO.C14H19NO/c1-14-2-4-15(5-3-14)17(8-9-17)10-13-18-11-6-16(19)7-12-18;1-13-2-4-14(5-3-13)16(6-7-16)8-10-18-11-9-17-15(19)12-18;1-14-2-4-15(5-3-14)16(6-7-16)8-9-17-10-12-20(18,19)13-11-17;1-13-2-4-14(5-3-13)16(7-8-16)9-11-17-10-6-15(18)12-17;1-14-2-4-15(5-3-14)16(6-7-16)8-9-17-10-12-18-13-11-17;1-12(2)15(18)17-11-10-16(8-9-16)14-6-4-13(3)5-7-14;1-12-3-5-13(6-4-12)15(7-8-15)9-10-17(2)11-14(16)18;1-12-4-6-14(7-5-12)15(8-9-15)10-11-16(3)13(2)17;1-13-3-5-14(6-4-13)15(7-8-15)9-10-16(2)11-12-17;1-11-3-5-13(6-4-11)14(7-8-14)9-10-15-12(2)16/h2-5,16,19H,6-13H2,1H3;2-5H,6-12H2,1H3,(H,17,19);2-5H,6-13H2,1H3;2-5,15,18H,6-12H2,1H3;2-5H,6-13H2,1H3;4-7,12H,8-11H2,1-3H3,(H,17,18);3-6H,7-11H2,1-2H3,(H2,16,18);4-7H,8-11H2,1-3H3;3-6,17H,7-12H2,1-2H3;3-6H,7-10H2,1-2H3,(H,15,16)/t;;;15-;;;;;;/m...0....../s1.
What are the key properties of N-methyl-N-[2-[1-(4-methylphenyl)cyclopropyl]ethyl]acetamide;2-[methyl-[2-[1-(4-methylphenyl)cyclopropyl]ethyl]amino]acetamide;2-[methyl-[2-[1-(4-methylphenyl)cyclopropyl]ethyl]amino]ethanol;2-methyl-N-[2-[1-(4-methylphenyl)cyclopropyl]ethyl]propanamide;N-[2-[1-(4-methylphenyl)cyclopropyl]ethyl]acetamide;4-[2-[1-(4-methylphenyl)cyclopropyl]ethyl]morpholine;4-[2-[1-(4-methylphenyl)cyclopropyl]ethyl]piperazin-2-one;1-[2-[1-(4-methylphenyl)cyclopropyl]ethyl]piperidin-4-ol;(3S)-1-[2-[1-(4-methylphenyl)cyclopropyl]ethyl]pyrrolidin-3-ol;4-[2-[1-(4-methylphenyl)cyclopropyl]ethyl]-1,4-thiazinane 1,1-dioxide?
N-methyl-N-[2-[1-(4-methylphenyl)cyclopropyl]ethyl]acetamide;2-[methyl-[2-[1-(4-methylphenyl)cyclopropyl]ethyl]amino]acetamide;2-[methyl-[2-[1-(4-methylphenyl)cyclopropyl]ethyl]amino]ethanol;2-methyl-N-[2-[1-(4-methylphenyl)cyclopropyl]ethyl]propanamide;N-[2-[1-(4-methylphenyl)cyclopropyl]ethyl]acetamide;4-[2-[1-(4-methylphenyl)cyclopropyl]ethyl]morpholine;4-[2-[1-(4-methylphenyl)cyclopropyl]ethyl]piperazin-2-one;1-[2-[1-(4-methylphenyl)cyclopropyl]ethyl]piperidin-4-ol;(3S)-1-[2-[1-(4-methylphenyl)cyclopropyl]ethyl]pyrrolidin-3-ol;4-[2-[1-(4-methylphenyl)cyclopropyl]ethyl]-1,4-thiazinane 1,1-dioxide has a molecular weight of 2475.65 g/mol, XLogP of 24.91, 45 rotatable bonds, 7 hydrogen bond donors, and 18 hydrogen bond acceptors.
Where does this data come from?
All data for N-methyl-N-[2-[1-(4-methylphenyl)cyclopropyl]ethyl]acetamide;2-[methyl-[2-[1-(4-methylphenyl)cyclopropyl]ethyl]amino]acetamide;2-[methyl-[2-[1-(4-methylphenyl)cyclopropyl]ethyl]amino]ethanol;2-methyl-N-[2-[1-(4-methylphenyl)cyclopropyl]ethyl]propanamide;N-[2-[1-(4-methylphenyl)cyclopropyl]ethyl]acetamide;4-[2-[1-(4-methylphenyl)cyclopropyl]ethyl]morpholine;4-[2-[1-(4-methylphenyl)cyclopropyl]ethyl]piperazin-2-one;1-[2-[1-(4-methylphenyl)cyclopropyl]ethyl]piperidin-4-ol;(3S)-1-[2-[1-(4-methylphenyl)cyclopropyl]ethyl]pyrrolidin-3-ol;4-[2-[1-(4-methylphenyl)cyclopropyl]ethyl]-1,4-thiazinane 1,1-dioxide is sourced from PubChem (CID 160771056), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).